141 related articles for article (PubMed ID: 12379777)
1. Molecular alterations of h-warts/LATS1 tumor suppressor in human soft tissue sarcoma.
Hisaoka M; Tanaka A; Hashimoto H
Lab Invest; 2002 Oct; 82(10):1427-35. PubMed ID: 12379777
[TBL] [Abstract][Full Text] [Related]
2. Zyxin, a regulator of actin filament assembly, targets the mitotic apparatus by interacting with h-warts/LATS1 tumor suppressor.
Hirota T; Morisaki T; Nishiyama Y; Marumoto T; Tada K; Hara T; Masuko N; Inagaki M; Hatakeyama K; Saya H
J Cell Biol; 2000 May; 149(5):1073-86. PubMed ID: 10831611
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of the h-warts/LATS1 gene in human breast cancer.
Morinaga N; Shitara Y; Yanagita Y; Koida T; Kimura M; Asao T; Kimijima I; Takenoshita S; Hirota T; Saya H; Kuwano H
Int J Oncol; 2000 Dec; 17(6):1125-9. PubMed ID: 11078797
[TBL] [Abstract][Full Text] [Related]
4. A human homolog of Drosophila warts tumor suppressor, h-warts, localized to mitotic apparatus and specifically phosphorylated during mitosis.
Nishiyama Y; Hirota T; Morisaki T; Hara T; Marumoto T; Iida S; Makino K; Yamamoto H; Hiraoka T; Kitamura N; Saya H
FEBS Lett; 1999 Oct; 459(2):159-65. PubMed ID: 10518011
[TBL] [Abstract][Full Text] [Related]
5. Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma.
Seidel C; Schagdarsurengin U; Blümke K; Würl P; Pfeifer GP; Hauptmann S; Taubert H; Dammann R
Mol Carcinog; 2007 Oct; 46(10):865-71. PubMed ID: 17538946
[TBL] [Abstract][Full Text] [Related]
6. Reverse transcriptase-polymerase chain reaction amplification of MDR1 gene expression in adult soft tissue sarcomas.
Oda Y; Schneider-Stock R; Ryś J; Gruchała A; Niezabitowski A; Roessner A
Diagn Mol Pathol; 1996 Jun; 5(2):98-106. PubMed ID: 8727096
[TBL] [Abstract][Full Text] [Related]
7. LATS1 tumor suppressor regulates G2/M transition and apoptosis.
Xia H; Qi H; Li Y; Pei J; Barton J; Blackstad M; Xu T; Tao W
Oncogene; 2002 Feb; 21(8):1233-41. PubMed ID: 11850843
[TBL] [Abstract][Full Text] [Related]
8. Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction.
St John MA; Tao W; Fei X; Fukumoto R; Carcangiu ML; Brownstein DG; Parlow AF; McGrath J; Xu T
Nat Genet; 1999 Feb; 21(2):182-6. PubMed ID: 9988269
[TBL] [Abstract][Full Text] [Related]
9. Mutational and expressional analyses of NRF2 and KEAP1 in sarcomas.
Je EM; An CH; Yoo NJ; Lee SH
Tumori; 2012; 98(4):510-5. PubMed ID: 23052169
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning of a novel human protein kinase, kpm, that is homologous to warts/lats, a Drosophila tumor suppressor.
Hori T; Takaori-Kondo A; Kamikubo Y; Uchiyama T
Oncogene; 2000 Jun; 19(27):3101-9. PubMed ID: 10871863
[TBL] [Abstract][Full Text] [Related]
11. Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene.
Stratton MR; Moss S; Warren W; Patterson H; Clark J; Fisher C; Fletcher CD; Ball A; Thomas M; Gusterson BA
Oncogene; 1990 Sep; 5(9):1297-301. PubMed ID: 2216456
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional activation of the Lats1 tumor suppressor gene in tumors of CUX1 transgenic mice.
Siam R; Harada R; Cadieux C; Battat R; Vadnais C; Nepveu A
Mol Cancer; 2009 Aug; 8():60. PubMed ID: 19656388
[TBL] [Abstract][Full Text] [Related]
13. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas.
Mousses S; McAuley L; Bell RS; Kandel R; Andrulis IL
Mod Pathol; 1996 Jan; 9(1):1-6. PubMed ID: 8821948
[TBL] [Abstract][Full Text] [Related]
14. p53 gene mutations and p53 protein expression in human soft tissue sarcomas.
Yoo J; Lee HK; Kang CS; Park WS; Lee JY; Shim SI
Arch Pathol Lab Med; 1997 Apr; 121(4):395-9. PubMed ID: 9140310
[TBL] [Abstract][Full Text] [Related]
15. Uterine sarcomas express KIT protein but lack mutation(s) in exon 11 or 17 of c-KIT.
Rushing RS; Shajahan S; Chendil D; Wilder JL; Pulliam J; Lee EY; Ueland FR; van Nagell JR; Ahmed MM; Lele SM
Gynecol Oncol; 2003 Oct; 91(1):9-14. PubMed ID: 14529657
[TBL] [Abstract][Full Text] [Related]
16. p53 abnormalities in different subtypes of human sarcomas.
Andreassen A; Oyjord T; Hovig E; Holm R; Flørenes VA; Nesland JM; Myklebost O; Høie J; Bruland OS; Børresen AL
Cancer Res; 1993 Feb; 53(3):468-71. PubMed ID: 8425179
[TBL] [Abstract][Full Text] [Related]
17. WARTS tumor suppressor is phosphorylated by Cdc2/cyclin B at spindle poles during mitosis.
Morisaki T; Hirota T; Iida S; Marumoto T; Hara T; Nishiyama Y; Kawasuzi M; Hiraoka T; Mimori T; Araki N; Izawa I; Inagaki M; Saya H
FEBS Lett; 2002 Oct; 529(2-3):319-24. PubMed ID: 12372621
[TBL] [Abstract][Full Text] [Related]
18. Molecular and immunohistochemical p53 status in liposarcoma and malignant fibrous histiocytoma: identification of seven new mutations for soft tissue sarcomas.
Taubert H; Würl P; Meye A; Berger D; Thamm B; Neumann K; Hinze R; Schmidt H; Rath FW
Cancer; 1995 Oct; 76(7):1187-96. PubMed ID: 8630896
[TBL] [Abstract][Full Text] [Related]
19. PTEN/MMAC1 gene mutation is a rare event in soft tissue sarcomas without specific balanced translocations.
Saito T; Oda Y; Kawaguchi K; Takahira T; Yamamoto H; Tamiya S; Tanaka K; Matsuda S; Sakamoto A; Iwamoto Y; Tsuneyoshi M
Int J Cancer; 2003 Mar; 104(2):175-8. PubMed ID: 12569572
[TBL] [Abstract][Full Text] [Related]
20. Possible association between tumor-suppressor gene mutations and hMSH2/hMLH1 inactivation in alveolar soft part sarcoma.
Saito T; Oda Y; Kawaguchi K; Takahira T; Yamamoto H; Sakamoto A; Tamiya S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2003 Sep; 34(9):841-9. PubMed ID: 14562278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
